Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs)
The DOI matches its Crossref record; 74 of the 74 references it cites were found in a registry or an index.
Abstract
Polycystic ovary syndrome (PCOS) is a heterogeneous disorder of unclear etiopathogenesis that is likely to involve genetic and environmental components synergistically contributing to its phenotypic expression. Endocrine disrupting chemicals (EDCs) and in particular Bisphenol A (BPA) represent a group of widespread pollutants intensively investigated as possible environmental contributors to PCOS pathogenesis. Substantial evidence from in vitro and animal studies incriminates endocrine disruptors in the induction of reproductive and metabolic aberrations resembling PCOS characteristics. In humans, elevated BPA concentrations are observed in adolescents and adult PCOS women compared to reproductively healthy ones and are positively correlated with hyperandrogenemia, implying a potential role of the chemical in PCOS pathophysiology, although a causal interference cannot yet be established. It is plausible that developmental exposure to specific EDCs could permanently alter neuroendocrine, reproductive and metabolic regulation favoring PCOS development in genetically predisposed individuals or it could accelerate and/or exacerbate the natural course of the syndrome throughout life cycle exposure.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Because of contributing factors that affect both conditions, including alterations in sex steroid synthesis, inflammation, and/or toxic exposures, women with endometriosis might exhibit an increased risk of PCOS.16,17”
From Examining the co-occurrence of endometriosis and polycystic ovarian syndrome (2023) · cites this paper as [16]
Citations
Cites
Endocrine-Disrupting Chemicals: An Endocrine Society Scientific Statement
Diamanti-Kandarakis, E., Bourguignon, J.-P., Giudice, L. C., Hauser, R., Prins, G. S., Soto, A. M., Zoeller, R. T., & Gore, A. C. (2009) · Endocrine Reviews · doi:10.1210/er.2009-0002 · Cited by 4,585 · cited 3×
“The role of the environment in PCOS pathogenesis has recently expanded to include a broad category of industrial chemicals that are widespread distributed in the atmosphere and have the potency to interfere with all hormone-sensitivity systems [12].”
BackgroundSelf-citationHuman exposure to bisphenol A (BPA)
Vandenberg, L. N., Hauser, R., Marcus, M., Olea, N., & Welshons, W. V. (2007) · Reproductive Toxicology · doi:10.1016/j.reprotox.2007.07.010 · Cited by 2,885 · cited 1×
“Bisphenol A (BPA) a ubiquitous chemical widely used in the manufacture of polycarbonate plastics and epoxy resins [16].”
BackgroundThe Prevalence and Features of the Polycystic Ovary Syndrome in an Unselected Population
Azziz, R., Woods, K. S., Reyna, R., Key, T. J., Knochenhauer, E. S., & Yildiz, B. O. (2004) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-032046 · Cited by 2,712
Diamanti-Kandarakis, E., & Dunaif, A. (2012) · Endocrine Reviews · doi:10.1210/er.2011-1034 · Cited by 1,947
Self-citationTeede, H., Deeks, A., & Moran, L. (2010) · BMC Medicine · doi:10.1186/1741-7015-8-41 · Cited by 1,565 · cited 1×
“er disease and high risk of cardiovascular disease [42, 43].”
Lang, I. A. (2008) · JAMA · doi:10.1001/jama.300.11.1303 · Cited by 1,458
Asunción, M., Calvo, R. M., San Millán, J. L., Sancho, J., Avila, S., & Escobar-Morreale, H. F. (2000) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.85.7.6682 · Cited by 1,318
Diamanti‐Kandarakis, E., Kouli, C., Bergiele, A. T., Filandra, F. A., Tsianateli, T. C., Spina, G., Zapanti, E. D., & Bartzis, M. I. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.84.11.4006 · Cited by 1,110
Self-citationDumesic, D. A., Oberfield, S. E., Stener-Victorin, E., Marshall, J. C., Laven, J. S., & Legro, R. S. (2015) · Endocrine Reviews · doi:10.1210/er.2015-1018 · Cited by 1,020 · cited 1×
“Cardinal features of the syndrome are reproductive and metabolic aberrations central to which is abnormal gonadotropin secretion, disrupted ovarian follicular maturation and steroid hormones secretion as well as disturbed insulin action leading to insulin resistance and compensatory hyperinsulinemia [5, 6].”
BackgroundExposure to bisphenol A advances puberty
Howdeshell, K. L., Hotchkiss, A. K., Thayer, K. A., Vandenbergh, J. G., & vom Saal, F. S. (1999) · Nature · doi:10.1038/44517 · Cited by 820 · cited 1×
“Acceleration of puberty onset (indicated by early vaginal opening) has been reported in rodents intrauterine exposed to environmentally relevant BPA levels [30, 31].”
Background
Research works printed but not linked: 1
- U.S. EPAOffice of Research and Development. Special report on environmental endocrine disruption: an effects assessment and analysis. Washington D.C.: Office of Research and Development, 1997, EPA/630-R96/012; 1997.
Cited by
Polycystic Ovary Syndrome: Etiology, Current Management, and Future Therapeutics
Singh, S., Pal, N., Shubham, S., Sarma, D. K., Verma, V., Marotta, F., & Kumar, M. (2023) · Journal of Clinical Medicine · doi:10.3390/jcm12041454 · Cited by 521
“It is conceivable that developmental exposure to particular EDCs could alter metabolic, reproductive, and neuroendocrine regulation permanently in ways that favor PCOS development in people who are genetically predisposed to it, or that it could hasten and/or exacerbate the syndrome’s natural course throughout life cy…”
BackgroundPolycystic Ovary Syndrome: A Comprehensive Review of Pathogenesis, Management, and Drug Repurposing
Sadeghi, H. M., Adeli, I., Calina, D., Docea, A. O., Mousavi, T., Daniali, M., Nikfar, S., Tsatsakis, A., & Abdollahi, M. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23020583 · Cited by 445
“Its obesogenic influence includes upregulation of adipogenesis-related genes [30], stimulation of adipocytes differentiation [28,30], potentiation of the accumulation of lipid in cells incorporated in medical syndrome, and triggering the conversion of target cells to adipocytes via phosphatidylinositol 3-kinase pathwa…”
BackgroundInfluentialRickard, B. P., Rizvi, I., & Fenton, S. E. (2022) · Toxicology · doi:10.1016/j.tox.2021.153031 · Cited by 334
Hyperandrogenemia and insulin resistance: The chief culprit of polycystic ovary syndrome
Wang, J., Wu, D., Guo, H., & Li, M. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116940 · Cited by 322
Physiological Aspects of Female Fertility: Role of the Environment, Modern Lifestyle, and Genetics
Hart, R. J. (2016) · Physiological Reviews · doi:10.1152/physrev.00023.2015 · Cited by 228
Metadata
- Authors
- Palioura, E., & Diamanti-Kandarakis, E.
- Affiliations
- Athens Euroclinic (GR)
- Venue
- Reviews in Endocrine and Metabolic Disorders
- Published
- 2015-12
- Volume
- 16
- Issue
- 4
- Pages
- 365-371
- ISSN
- 1389-9155 (ISSN-L)
- 1573-2606
- OpenAlex
- W2259394681
- Cited by
- 161
- References
- 73
- Citations by year
- 2026: 11 · 2025: 24 · 2024: 18 · 2023: 34 · 2022: 18 · 2021: 10 · 2020: 13 · 2019: 9 · 2018: 9 · 2017: 7 · 2016: 8
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- www.springer.com/tdm (tdm)
- Locations
- Reviews in Endocrine and Metabolic Disorders (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Reproductive Medicine › Ovarian function and disorders
- Physical Sciences › Environmental Science › Health, Toxicology and Mutagenesis › Effects and risks of endocrine disrupting chemicals
- Health Sciences › Medicine › Reproductive Medicine › Reproductive Biology and Fertility
- Keywords
- polycystic ovary syndrome, endocrine disruptors, bisphenol A, hyperandrogenemia, PCOS pathogenesis, environmental exposure, early life exposure, reproductive disorders, metabolic abnormalities, genetic susceptibility
- MeSH terms
- Bisphenol A Compounds, Adolescent, Benzhydryl Compounds, Female, Humans, Phenols, Polycystic Ovary Syndrome, Hyperandrogenism, Endocrine Disruptors
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs). https://app.cochat.ai/papers/10.1007/s11154-016-9326-7
- The paper
- Palioura, E., & Diamanti-Kandarakis, E. (2015). Polycystic ovary syndrome (PCOS) and endocrine disrupting chemicals (EDCs). Reviews in Endocrine and Metabolic Disorders. https://doi.org/10.1007/s11154-016-9326-7
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.